SCHEMBL1769433

SCHEMBL1769433

O=[N+]([O-])c1ccc(C2(CO)CC2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 3/20 0.47
▸ CES1 P23141 1/20 0.42
▸ NPC1 O15118 1/20 0.42
▸ RAB9A P51151 1/20 0.42
▸ CA1 P00915 2/20 0.41
▸ CA2 P00918 2/20 0.41
▸ LOXL2 Q9Y4K0 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ ALDH1A1 P00352 4/20 0.41
▸ ACHE P22303 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41
▸ CYP2C19 P33261 2/20 0.41
▸ GSK3B P49841 1/20 0.41
▸ MAPT P10636 1/20 0.40
▸ HTR1E P28566 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ S1PR3 Q99500 1/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ CYP1A2 P05177 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3237033 0.93 TSHR (0.44) TSHRCES1NPC1RAB9ACA1
SCHEMBL16423195 0.89 L3MBTL1 (0.47) TSHRTDP1ALDH1A1MAPTLMNA
SCHEMBL2817503 0.81 MAOA (0.52) TSHRCA1CA2LOXL2ALDH1A1
SCHEMBL14176144 0.81 ATM (0.49) TSHRCA1CA2LOXL2ALDH1A1
SCHEMBL20476006 0.80 TSHR (0.47) TSHRCES1CA1CA2LOXL2
SCHEMBL2817383 0.76 NPC1 (0.50) TSHRNPC1TDP1ALDH1A1MAPT
SCHEMBL3229047 0.75 NPC1 (0.40) TSHRNPC1RAB9ALOXL2ALDH1A1
SCHEMBL1769357 0.74 SLC6A2 (0.46) LOXL2ALDH1A1ACHEMAPTHTR1E
SCHEMBL1769275 0.74 POLB (0.39) TSHRCA1CA2ALDH1A1ACHE
SCHEMBL6612675 0.74 ALDH1A1 (0.44) TSHRCA1CA2ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011061760-A1 NOVEL ANTITHROMBOTIC AGENTS CADILA HEALTHCARE LIMITED (IN) 2011-05-26 — — WO disclosed
WO-2011061760-A1 NOVEL ANTITHROMBOTIC AGENTS CADILA HEALTHCARE LIMITED (IN) 2011-05-26 — — WO disclosed
US-7381732-B2 Pyrazolobenzamides and derivatives as factor Xa inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2008-06-03 — — US disclosed
US-7312214-B2 1, 1-disubstituted cycloalkyl derivatives as factor Xa inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2007-12-25 — — US disclosed
US-7250415-B2 1,1-Disubstitutedcycloalkyl-, glycinamidyl-, sulfonyl-amidino-, and tetrahydropyrimidinyl-containing diaminoalkyl, β-aminoacids, α-aminoacids and derivatives thereof as factor Xa inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2007-07-31 — — US disclosed
WO-2005034837-A2 7H-IMIDAZO [1,2-α] PYRAZIN-8-ONE COMPOUNDS AS ION CHANNEL MODULATORS CARDIOME PHARMA CORPORATION (US) 2005-04-21 — — WO disclosed
Send feedback